<DOC>
	<DOCNO>NCT00912756</DOCNO>
	<brief_summary>Recently , Nanto et al . report cilostazol effectively prevent restenosis retrospective analysis 121 femoropopliteal artery lesion percutaneous transluminal angioplasty ( PTA ) patient undergone PTA . In prospective 3-year follow-up study 127 patient similar disease , patency rate significantly high cilostazol group ticlopidine group . It also find cilostazol markedly inhibited restenosis first 1-year period follow endovascular therapy restenosis frequently observe . In addition , sporadic report cilostazol effective prevent post-stenting restenosis coronary artery area . Based result , multicenter study go conduct prospectively evaluate usefulness cilostazol lower limb endovascular therapy .</brief_summary>
	<brief_title>Sufficient Treatment Peripheral Intervention Cilostazol</brief_title>
	<detailed_description />
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Arteriosclerosis Obliterans</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Patient criterion : Chronic arteriosclerosis obliterans afflict femoropopliteal artery area* Patients monitor least 2 year surgery Lesion criterion : Angiographicallyconfirmed new significant superficial femoral artery stenosis occlusive lesion 30 cm long less stented At least 1 arterial runoff knee ; stenosis lesion limit flow may include . Occlusive lesion may include . Exclusion criterion : Patients risk hemorrhagic complication patient bleed tendency Patients congestive cardiac failure Patients drugeluting stent Patients acute low limb ischemia Patients creatinine 2 mg/dL ( without dialysis ) patient history serious adverse reaction leukopenia , hepatic dysfunction , renal dysfunction , hypersensitivity component study drug . Lesion criterion : Remnant inflow Severe calcification No arterial runoff knee</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>endovascular therapy</keyword>
	<keyword>restenosis</keyword>
	<keyword>cilostazol</keyword>
	<keyword>femoropopliteal artery lesion</keyword>
	<keyword>Chronic arteriosclerosis obliterans afflict femoropopliteal artery area</keyword>
</DOC>